Journal of clinical and experimental hematopathology : JCEH
about
A case of extramedullary plasmablastic plasmacytoma successfully treated using a combination of thalidomide and dexamethasone and a review of the medical literatureCADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphomaEpstein-Barr virus-negative, CD5-positive diffuse large B-cell lymphoma developing after treatment with oral tacrolimus for mixed connective tissue disease : a case report and review of the literatureHematopoietic stem cell transplantation for follicular lymphoma: optimal timing and indicationPathology of follicular lymphomaCD56+ angioimmunoblastic T-cell lymphoma with evans syndrome : a case report and review of the literatureCoexistent t(8;21)(q22;q22) Translocation and 5q Deletion in Acute Myeloid LeukemiaEarly-Onset Severe Diffuse Alveolar Hemorrhage after Bortezomib Administration Suggestive of Pulmonary Involvement of Myeloma CellsComplete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.Prediction of clinical outcome in patients with idiopathic thrombocytopenic purpura by evaluating bone marrow clot CD20+ B lymphocytes and morphological changes of megakaryocytes.Primary mediastinal non-seminomatous germ cell tumor associated with hemophagocytic syndrome.Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly : a clinical report of five cases.Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute.Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection.Bone marrow macrophages in Waldenström's macroglobulinemia: a report of four cases.Efficacy of molecular response at 1 or 3 months after the initiation of dasatinib treatment can predict an improved response to dasatinib in imatinib-resistant or imatinib-intolerant Japanese patients with chronic myelogenous leukemia during the chrT-Cell Prolymphocytic Leukemia, Small Cell Variant, Possibly at the Stage of Intracytoplasmic Expression of CD3 in T-Cell Ontogenesis.Granulomatous lymphadenitis.Immunohistochemical detection of possible cellular origin of hepatic histiocytic sarcoma in mice.A family predisposition to adult T-cell leukemia.Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma.Secondary sea-blue histiocytosis derived from Niemann-Pick disease.Myelomatous meningitis evaluated by multiparameter flow cytometry : report of a case and review of the literature.Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review.Pyothorax-associated lymphoma.Pathogenetic and clinical implications of non-immunoglobulin ; BCL6 translocations in B-cell non-Hodgkin's lymphoma.Mitogenic signals initiated via interleukin-6 receptor complexes in cooperation with other transmembrane molecules in myelomas.Spontaneous regression of diffuse large B-cell lymphoma harbouring Epstein-Barr virus: a case report and review of the literature.MALT lymphoma : recent advances in aetiology and molecular genetics.Radioimmunotherapy for non-hodgkin lymphoma : historical perspective and current status.Grade I lymphomatoid granulomatosis with increased uptake of [18F] fluorodeoxyglucose in positron emission tomography: a case report.Human herpesvirus 6 in hematological malignancies.Superior clinical impact of FDG-PET compared to MRI for the follow-up of a patient with sacral lymphoma.HTLV-1 and the host immune system: how the virus disrupts immune regulation, leading to HTLV-1 associated diseases.Treatment of adult T-cell leukemia.Mesenchymal stromal cells for graft-versus-host disease : basic aspects and clinical outcomes.11q23/MLL acute leukemia : update of clinical aspects.Importance of relative dose intensity in chemotherapy for diffuse large B-cell lymphoma.
P1433
Q26824641-04127D6F-9FE4-4ED4-80D0-E4D42283DCB1Q26830288-6B36A23C-7310-4436-8983-4C06DC0831E7Q27008550-10551701-4BC6-47E8-ADEF-677252B8008CQ27010435-7B93DE65-C466-45A0-B4DA-36DDB8C71824Q27014878-2993922F-18FE-4956-B7F0-A5BA6174C04FQ27026831-91BC4872-D8A1-4455-BD7C-9991C1576035Q28069700-537B4B1B-49A8-408B-A870-1FBC45213563Q28080237-0A232ECC-641D-4E06-B624-6BC06A4DDE9DQ33162942-BDBAD418-A3EB-4CAA-8F62-CFD7B05F06DEQ33379395-EFC92E5D-663E-4145-B09F-71724DD90816Q33387022-3B68BE17-86F8-427D-B397-3CACCEAA999DQ33408651-45B1177A-EA69-403A-AB24-C8CD23A03489Q33408655-EA5FAE99-66C6-44F7-B09E-77BD48F4146DQ33408657-E852AE54-0693-4CCC-839B-A73F23841B52Q33408659-BB0F3111-6035-4D49-B3A5-2CAC9D0A158EQ33410104-652B01C5-E910-4CF9-A294-8DE0F286FA50Q33418221-8EE2CB60-226E-425C-81B0-EB99B08DBDF6Q33419298-596AC363-F16A-4931-9596-B886E605D48CQ33423857-43692F99-37E1-42C8-8D55-E0BCC253892AQ34282194-7A0E591A-7750-4991-9650-7E7259918436Q34523218-EB299466-740F-4D02-A81D-2E756E9CA4B6Q34586774-64927D92-2279-430D-8F9D-E1252D44B395Q34629481-BCA97F82-72D9-4F04-9CA0-CFFF4CB29DD9Q34629487-D2408A28-08A3-41A8-A8F8-D3709852CC59Q35334784-38A6254F-5B34-42A0-96DF-DAB6A688ADB1Q36632089-25033D49-A38F-4999-B08D-9C1307F81965Q36632092-4C4DA7EC-7EF5-4997-95A0-E9320A714C90Q36672279-77A3F74D-F304-4B49-9584-DC22FCFD3F38Q36672283-46B91268-A689-4C7B-A126-5FC3DB76FC3CQ36825561-97253316-38BB-4B0B-980F-210B437B3D00Q37015216-2CE526CF-10AD-424E-BF1B-A119C04E487DQ37015221-77AE883D-8148-4068-B104-4D2682D41923Q37497987-B3F6D95D-19EE-4A65-92EF-B2CF86F3B5F5Q37631313-59B3A3F6-016C-4D65-9C68-4F3E20A7A399Q37631315-F73DC4FE-2190-4282-B0A7-99252E2F4350Q37760997-4007D62E-E762-4194-86ED-46997BE4482DQ37760998-8CBA78A4-D0E3-4A91-989C-F0834D165A92Q37814791-A7093C49-CAC8-4FE0-8B3C-6F44E0689C64Q37814793-E3D2B0F2-60EA-4898-9030-94BFB16EE5C0Q37882921-68241CD9-10C5-487F-8FF2-431F30C421C4
P1433
Journal of clinical and experimental hematopathology : JCEH
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Journal of clinical and experimental hematopathology : JCEH
@ast
Journal of clinical and experimental hematopathology : JCEH
@en
Journal of clinical and experimental hematopathology : JCEH
@es
Journal of clinical and experimental hematopathology : JCEH
@it
Journal of clinical and experimental hematopathology : JCEH
@nl
type
label
Journal of clinical and experimental hematopathology : JCEH
@ast
Journal of clinical and experimental hematopathology : JCEH
@en
Journal of clinical and experimental hematopathology : JCEH
@es
Journal of clinical and experimental hematopathology : JCEH
@it
Journal of clinical and experimental hematopathology : JCEH
@nl
prefLabel
Journal of clinical and experimental hematopathology : JCEH
@ast
Journal of clinical and experimental hematopathology : JCEH
@en
Journal of clinical and experimental hematopathology : JCEH
@es
Journal of clinical and experimental hematopathology : JCEH
@it
Journal of clinical and experimental hematopathology : JCEH
@nl
P3181
P1055
P1156
5000158305